Agonism of β3-Adrenoceptors Inhibits Pathological Retinal Angiogenesis in the Model of Oxygen-Induced Retinopathy
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.10.34 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Investigative Ophthalmology & Visual Science, 2024. Verfasst von Alberto Melecchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Retinal Neovascularization, Disease Models, Animal, Oxygen, Adrenergic beta-3 Receptor Agonists. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Pisa, Pisa, Italy.
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Neonatology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Zitieren
APA
Melecchi, A., Canovai, A., Amato, R., Dal Monte, M., Filippi, L., Bagnoli, P., & Cammalleri, M. (2024). Agonism of β3-Adrenoceptors Inhibits Pathological Retinal Angiogenesis in the Model of Oxygen-Induced Retinopathy. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.10.34
Vancouver
Melecchi A, Canovai A, Amato R, Dal Monte M, Filippi L, Bagnoli P, et al. Agonism of β3-Adrenoceptors Inhibits Pathological Retinal Angiogenesis in the Model of Oxygen-Induced Retinopathy. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.10.34
BibTeX
@article{Melecchi2024,
author = {Melecchi, Alberto and Canovai, Alessio and Amato, Rosario and Dal Monte, Massimo and Filippi, Luca and Bagnoli, Paola and Cammalleri, Maurizio},
title = {Agonism of β3-Adrenoceptors Inhibits Pathological Retinal Angiogenesis in the Model of Oxygen-Induced Retinopathy},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.10.34}
}
EUVIMED